Community health worker support for blood pressure medicine in refugees
Tests a community health worker program to help refugees with high blood pressure take medicine.
Key facts
- Who runs it
- University of California, San Diego
- Where
- San Diego, United StatesSee the 2 sites
- Trial code
- Registry title
- Blood Pressure Care for Advancing Real-World Evidence (BPCARE)
- Status
- Recruiting
- People taking part
- 250 people, planned
- Started
- 9 Jan 2026
- Expected to end
- May 2030
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- BPCARE Intervention
- Record updated
- 9 February 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adult refugees in San Diego with high blood pressure who take blood pressure medicine. It tests a community health worker program to help people take their medicine.
- Age
- 21 years or older
- Sex
- All sexes
- Disease stage
- Diagnosed high blood pressure (hypertension). Needs a clinic systolic reading of at least 130 mmHg or a home systolic reading of 140 mmHg or more in the last year, and/or a missed dose of medicine within the last two months.
Main reasons for not taking part
- Heart event or hospital stay for unstable angina in the last 3 months
- Heart failure with symptoms in the last 6 months, or ejection fraction below 35%
- Pregnant, or planning pregnancy in the next 7 months
- Taking part in another trial with medicines that may change blood pressure
- Dementia, psychotic disorder or other problems that limit understanding or following the study
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Have a clinical diagnosis of hypertension determined at screening,
- Be at least 21 years of age,
- English as a second language,
- Be able to provide written informed consent and participate in study procedures,
- Have a last least one recorded automated clinic systolic BP reading of at least 130 mmHg within the past year OR at least one home SBP reading of ≥140 mmHg in the last year. AND/OR answer is in range of less than two months to "when was the last time you missed a dose of your hypertension medication?"
- Will not move out of San Diego in the next 6 months, and
- Have access to a mobile phone or computer with video telecommunication capacity (e.g. Zoom)
Who cannot take part
- Current participation in another clinical trial that includes taking medications that may change blood pressure, or
- A cardiovascular event or hospitalization for unstable angina within last 3 months,
- Symptomatic heart failure within the past 6 months or left ventricular ejection fraction < 35%,
- Major factors judged to be likely to significantly limit comprehension of or adherence to interventions including dementia, psychotic disorders, or affect ability to conduct pill counts
- Individuals who are pregnant, planning on becoming pregnant within the next 7 months
- Any immediate family members participating in the trial
Where in United States
- Family Health Centers of San DiegoSan Diego, United StatesContact: Job Godino, PhDTaking people
- University of California San DiegoSan Diego, United StatesContact: Tala Al-Rousan, MD, MPHNo longer taking part
About the trial
What the trial wants to find out
The goal of this randomized clinical trial is to determine whether a community health worker-delivered, multi-component behavioral intervention can improve antihypertensive medication adherence and blood pressure control among adult refugees with hypertension who are prescribed antihypertensive medications.
Read full original descriptionShow less
The main questions it aims to answer are:
1. Does participation in the BPCARE intervention improve antihypertensive medication adherence compared to enhanced usual care? 2. Does participation in the BPCARE intervention improve blood pressure control and persistence over time compared to enhanced usual care?
Researchers will compare participants randomized to the BPCARE intervention to those receiving enhanced usual care (hypertension information and a home blood pressure monitor) to determine the effects on medication adherence, blood pressure control, and persistence.
Participants will:
* Be randomly assigned to either the BPCARE intervention or enhanced usual care * Receive hypertension education and a home blood pressure monitor * Participate in community health worker-delivered sessions that include hypertension and medication education, motivational interviewing, problem-solving, and action planning (intervention arm only) * Complete questionnaires assessing medication adherence and related psychosocial factors * Have blood pressure monitored using connected home blood pressure devices * Complete pill counts to assess medication adherence over a nine-month follow-up period
The 2 groups in the trial
- BPCARE Intervention ArmTreatment being tested
Participants in the BPCARE intervention arm will receive a translated educational booklet, a pill box for pill organization, and two intervention sessions focused on medication adherence within month 1 and 2 after randomization.
Treatment: BPCARE Intervention
- Standard Care Control ArmNo study treatment, for comparison
Participants in the control arm will not receive any additional support, but will still be conducting monthly pill counts, at home BP measurements, and in-person follow-up visits.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Blood Pressure Care for Advancing Real-World Evidence (BPCARE): an RCT of Adherence
- Plain-language title
- Community health worker support for blood pressure medicine in refugeesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 13 November 2026.
- Record updated
- 9 February 2026